Neha R. Patil, M.D.

(877) 460-4673
Neha R. Patil, M.D.
Medical Oncologist and Hematologist
Clinical Expertise
  • Hematology
  • Medical Oncology
Academic Appointments
  • Assistant Clinical Professor, Department of Medical Oncology & Therapeutics Research

Medical oncologist Neha Patil, M.D., is a second-generation physician who has made her father’s guidance — “Always remember, the patient comes first” — a cornerstone of her medical practice. Triple board certified in medical oncology, hematology and internal medicine, she serves patients at City of Hope® Antelope Valley, offering leading-edge treatment options emerging from oncologic research.

Dr. Patil earned her medical degree at the Jawahar Medical Foundation’s ACPM Medical College in Dhule, India, then went no to complete an internal medicine residency at the University of Alabama in Huntsville. While pursuing subspecialty training in hematology and oncology at Henry Ford Health System at Wayne State University in Detroit, she served as chief administrative fellow, was voted fellow of the year and received the Robert Chapman, M.D., Outstanding Fellow Award.

The co-author of 11 peer-reviewed publications when she joined City of Hope in 2024, Dr. Patil has been recognized with the Gynecologic Oncology Group Foundation’s Young Investigator Travel Award. Previously, she was a senior staff physician and lab director for hematology-oncology at North Mississippi Medical Center.

Location

Awards & Memberships

Awards

  • 2020 2020 HFCI Research ASCO Travel Award
  • 2020 Fellow of the Year Award
  • 2020 Robert Chapman MD Outstanding Fellow Award
  • 2018 GOG Foundation Young Investigator Travel Award
  • 2017 American Society of Bone Marrow Transplant (ASBMT) Travel Award
  • 2013 OAD Cheryl Grace Scholarship
  • 2009 The Student "Scholar" award and stipend

Memberships

  • American Society of Clinical Oncology (ASCO)
  • American Society of Hematology (ASH)
  • American Society of Bone Marrow Transplant (ASBMT)
  • American Medical Association (AMA)
  • American Association of Physicians of Indian origin (AAPI)
  • Gynecologic Oncology Group (GOG)
  • Medical Council of India (MCI)
  • Michigan Society of Hematology and Oncology (MSHO)
  • Medical Association of the State of Alabama (MASA)
  • Society of Hematologic Oncology (SOHO)

Publications

  • Askenazi DJ, Koralkar R, Hundley HE, Montesanti A, Patil N, Ambalavanan N. fluid overload and mortality are associated with acute kidney injury in sick near-term / Term Neonate. Pediatric Nephrology. 2013 Apr; 28(4): 661-666. Cited in PubMed; PMID: 23224224. Publication Status: Published.
  • Askenazi DJ, Koralkar R, Patil N, Halloran B, Ambalavanan N, Griffin R. Acute kidney injury urine biomarkers in very low birth weight infants. Clinical journal of the American Society of Nephrology. 2016 May; Publication status: published
  • Askenazi DJ, Halloran B, Patil N, Keeling S, Saeidi B, Koralkar R, Ambalavanan N. Genetic polymorphisms of Heme-oxygenase 1 may impact on acute kidney injury, Bronchopulmonary Dysplasia, and mortality in premature infants. Pediatric Research. 2015 Jun; 77(6):793-8. PMID: 25751573. Publication status: published.
  • Askenazi D, Patil N, Ambalavanan N, Balena-Borneman J, Lozano DJ, Ramani M, Collins M, Griffin RL. Acute kidney injury is associated with bronchopulmonary dysplasia / mortality in premature infants. Pediatric Nephrology. 2015 Sep; 30(9):1511-8. PMID: 25808019. Publication status: published.
  • Downes K, Patil N, Rao M, Koralkar R, Harris W, Clancy J, Goldstein S, Askenazi D. Risk Factors for acute kidney injury during aminoglycoside Therapy in patients with cystic fibrosis. Pediatric Nephrology. 2015 Oct; 30(10):1879-88. PMID: 25912993. Publication status: published.
  • Nour H, Patil N, Chewning J, Mineishi S, Saad A. Safety of repeated un-manipulated peripheral blood stem cell haploidentical transplant for graft failure. Bone marrow transplantation. 2016 Jun, Publication status: published.
  • Pandve H, Deshmukh P, Pandve R, Patil N. Role of youth in combating climate change. Indian journal of occupational and environmental medicine. 2009 Aug; 13(2): 105. PMID: 20386630. Publication status: published.
  • Patil, N, Herc E, Girgis M. Cold agglutinin disease and autoimmune hemolytic anemia with pulmonary embolism as a presentation of COVID-19 infection. Hematol Oncol Stem Cell Ther. 2020 Jul 6;S1658-3876(20)30116-3. PMID: 32645300. Publication status: published.
  • Patil, N, Khan G. Excellent and persistent response to single cycle of pembrolizumab immunotherapy in metastatic pancreatic adenocarcinoma patient with lynch syndrome. Am J Case Rep. 2020; 21: e923803-1–e923803-6. PMID: 32658872. Publication status: published
  • Patil, N, Salzman, D, Vaughan, W. Long-term Follow-up of a 10-year single-center experience with high-dose pharmacokinetics directed intravenous busulfan in combination with cyclophosphamide and etoposide as preparative regimen for intermediate-and high-grade Non-Hodgkin Lymphoma. ASCO annual meeting proceedings J Clin Oncol 32, 2014 (suppl; abstr e19521). Publication status: published.

Ratings & Reviews

Ratings and reviews below are gathered from the Press Ganey Clinician and Group Consumer Assessment of Healthcare Providers and Systems (CG CAHPS) survey. CG CAHPS is a standardized survey that is used to measure a patient's experience in the physician office setting. Ratings are an average of all responses to questions about a provider's care, with five stars being the highest.
5.0
Provider explain in way you understand
5.0
Provider listen carefully to you
4.9
Recommend this provider office
4.9
Know important info medical history
4.9
Show respect for what you say
4.9
Spend enough time with you
4.9
Rate provider 0-10
02/14/26
Good - Verified patient
02/14/26
Good experience - Verified patient
02/14/26
Very good - Verified patient
12/02/25
I feel very good and confident with the doctor - Verified patient
12/01/25
Dr. Patil is a very good Hematologist and she is very knowledgeable and personable. The entire nursing staff in infusion is great and professional. - Verified patient